|
Code:
ThOC
|
Time Slot/Poster Number:
11:10-11:25
|
Session:
Drug Discovery
|
Assessment of the Nano-Encapsulated Drug Delivery System for Bone Loss
|
| Qingwen Ni1; Hong Dixon2; yi-xian Qin3
|
1Texas A&M International University, Laredo, TX; 2Southwest Research Institute, San Antonio, TX; 3State University of New York at Stony Brook, Stony Brook, NY
|
| Abstract |
Bone loss, osteoporosis, is recognized as a significant problem in the space programs as well as a major health problem. The objective of this research is to establish a unique localized drug delivery system for bone loss in the critical region by developing a micro-nano encapsulated medicine protocol to accelerate local therapeutic effects, and by using a non-invasive NMR relaxation technique, and X-ray to evaluate the effectiveness of the formation. In this study we have demonstrated an effective, less toxic micro-nano encapsulated drug with designed concentrations, and controlled release-rate formation to prevent bone loss by preparation of enantiomers of promethazine, and employ an animal (rat) disuse hind limb suspension (HLS) rat model to determine the efficacy of the localized delivery.
|
|
Code:
ThOC
|
Time Slot/Poster Number:
11:25-11:50
|
Session:
Drug Discovery
|
Intermolecular Recognition and Drug Design by INPHARMA: How to Deal with Protein Dynamics and More.
|
| Teresa Carlomagno1; Julien Orts1; Benjamin Stauch1; Jennifer Tuma2; Christian Griesinger2; Ulrich Wendt3; Stefan Bartoschek3
|
1EMBL, Heidelberg, Germany; 2Max Planck Institute for Biophysical Chemistry, Gottingen, Germany; 3Chemical Sciences Structural Biology, Sanofi-Aventis, Germany
|
| Abstract |
Small molecules play a fundamental role in the functional regulation of molecular machines. The development of specific binders relies on the availability of structural information for the interaction of the target with low-affinity ligands, identified in screening experiments.
The INPHARMA method provides access to the relative binding-mode of low-affinity ligands to a common target. It requires two competitively-binding ligands and a structural model of the apo-receptor. In accordance with structure-based-drug-design workflows, the INPHARMA data are used to select binding modes from computer-generated docking poses. Here we show further developments of INPHARMA and benchmark its performance with respect to the parameters used in the data evaluation, i.e. the structural model of the apo-receptor and the internal dynamics of the binding pocket.
|
|
Code:
ThOC
|
Time Slot/Poster Number:
12:05-12:30
|
Session:
Drug Discovery
|
Covariance NMR and Web-Based Analysis of Molecules and Chemical Mixtures
|
| Fengli Zhang1; Steven L. Robinette1; David Snyder2; Lei Bruschweiler-Li1; Rafael Bruschweiler1
|
1Florida State University & NHMFL, Tallahassee, FL; 2William Paterson University, Wayne, New Jersey
|
| Abstract |
Elucidation of the composition of complex biological samples is a main focus of systems biology and metabolomics. In cases where the analysis of 1D NMR spectra is ambiguous, efficient and reliable 2D methods are required. We have explored the use of covariance NMR and its generalizations for this task to produce high-resolution spectra using a small number of increments. Homonuclear and heteronuclear covariance TOCSY spectra can be deconvoluted into 1D spectra of individual spin systems (DemixC), which can be efficiently screened against NMR spectral databases. Based on these principles, we have set up the COLMAR web server (http://spinportal.magnet.fsu.edu), which performs covariance processing, DemixC, and database query and which will be demonstrated for various examples.
|